Medicus Pharma (MDCX) Accounts Payables (2023 - 2025)

Medicus Pharma (MDCX) has reported Accounts Payables for 3 consecutive years, with $3.4 million the latest figure, recorded in Q4 2025.

• Accounts Payables for Q4 2025 came in at $3.4 million, up 167.42% year-over-year; the trailing twelve-month figure through Dec 2025 was $3.4 million (up 167.42% YoY), and the FY2025 annual result was $3.4 million, up 167.42% from the prior year.
• Accounts Payables was $3.4 million for Q4 2025 at Medicus Pharma, up from $2.0 million in the prior quarter.
• Over five years, Accounts Payables peaked at $3.4 million in Q4 2025 and troughed at $210842.0 in Q4 2023.
• Average Accounts Payables over 3 years is $1.8 million, with a median of $1.9 million recorded in 2025.
• Year-over-year, Accounts Payables soared 509.28% in 2024 and soared 167.42% in 2025.
• Over 3 years, Accounts Payables stood at $210842.0 in 2023, then jumped by 509.28% to $1.3 million in 2024, then jumped by 167.42% to $3.4 million in 2025.
• Per Business Quant data, the three most recent Accounts Payables figures were $3.4 million in Q4 2025, $2.0 million in Q3 2025, and $1.8 million in Q2 2025.